News
Wells Fargo Upgrades NeuroPace to Overweight, Raises Price Target to $20
14 Mar 24
News, Upgrades, Price Target, Analyst Ratings
The Latest Analyst Ratings For NeuroPace
12 Mar 24
Analyst Ratings
JP Morgan Maintains Overweight on NeuroPace, Raises Price Target to $17
12 Mar 24
News, Price Target, Analyst Ratings
NeuroPace Provides Full-year 2024 Revenue Guidance Of $73M-$77M, Est $74.598M
5 Mar 24
News, Guidance
Recap: NeuroPace Q4 Earnings
5 Mar 24
Earnings
NeuroPace Q4 2023 GAAP EPS $(0.23) Beats $(0.32) Estimate, Sales $18.01M Beat $17.46M Estimate
5 Mar 24
Earnings, Earnings Beats, News
Earnings Scheduled For March 5, 2024
5 Mar 24
Earnings
Earnings Preview: NeuroPace
4 Mar 24
Earnings
A Glimpse Into The Expert Outlook On NeuroPace Through 4 Analysts
22 Feb 24
Analyst Ratings
NeuroPace Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
30 Jan 24
Analyst Ratings
Leerink Partners Initiates Coverage On NeuroPace with Outperform Rating, Announces Price Target of $22
30 Jan 24
News, Price Target, Initiation, Analyst Ratings
Press releases
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
17 Apr 24
News, Press Releases
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference
27 Mar 24
News, Press Releases
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
5 Mar 24
Earnings, Press Releases